Increased prevalence of obstructive airways disease (OAD) in patients with ischemic heart disease (IHD) and hypertension (HT)

B. Brashier, N. Patel, S. Valsa, S. Mandrekar, S. Kulkarni, S. N. Gaikwad, S. V. Ghorpade, S. Salvi (Pune, Maharashtra, India)

Source: Annual Congress 2007 - Respiratory issues in primary care
Session: Respiratory issues in primary care
Session type: Thematic Poster Session
Number: 831
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
B. Brashier, N. Patel, S. Valsa, S. Mandrekar, S. Kulkarni, S. N. Gaikwad, S. V. Ghorpade, S. Salvi (Pune, Maharashtra, India). Increased prevalence of obstructive airways disease (OAD) in patients with ischemic heart disease (IHD) and hypertension (HT). Eur Respir J 2007; 30: Suppl. 51, 831

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The beta-blockers in combined treatment of coronary heart disease in patients with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2013 –COPD treatment
Year: 2013


Prevalence of chronic obstructive pulmonary disease (COPD) among smokers with stable coronary artery disease (CAD)
Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD
Year: 2019


Initial experience of sildenafil in patients with congenital heart disease (CHD) associated pulmonary arterial hypertension (PAH)
Source: Eur Respir J 2006; 28: Suppl. 50, 425s
Year: 2006

Pulmonary arterial hypertension (PAH) among end state renal disease (ESRD) patients under chronic hemodyalisis (HD)
Source: Eur Respir J 2007; 30: Suppl. 51, 345s
Year: 2007

Patient’s knowledge about risk factors for acute exacerbation( AE ) of chronic obstructive pulmonary disease( COPD )
Source: Eur Respir J 2004; 24: Suppl. 48, 514s
Year: 2004

LATE-BREAKING ABSTRACT: Risk factors for hospitalization and death in elderly smokers with chronic obstructive pulmonary disease (COPD) and/or chronic heart failure (CHF)
Source: International Congress 2016 – Long-term oxygen therapy, noninvasive ventilation, and other clinical variables in chronic lung diseases
Year: 2016

Do patients suffering from heart failure (HF) and chronic obstructive pulmonary disease (COPD) tolerate beta blocker (BB) treatment?
Source: Annual Congress 2011 - Comorbidities and management in primary care
Year: 2011



Predictors of arrhythmias in patients with chronic obstructive pulmonary disease (COPD).
Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies
Year: 2019

Frequency and features of formation of chronic kidney disease (CKD) in patients with chronic obstructive pulmonary disease.
Source: International Congress 2019 – Phenotypes and comorbidities of airway diseases
Year: 2019

The metabolic syndrome (MetS) in patients with chronic obstructive pulmonary disease (COPD) and its association with airway obstruction
Source: Annual Congress 2012 - COPD is not a pulmonary disease alone
Year: 2012


The estimation of respiratory muscles (RM) status by echodensitometry in men with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2012 - Various issues in clinical physiology
Year: 2012


Chronic obstructive pulmonary disease assessment test (CAT) in patients with COPD, chronic heart failure (CHF), and both
Source: International Congress 2016 – Features and impact of comorbidities in COPD
Year: 2016

Frequency of occurrence of risk factors of cardiovascular diseases and assessment of the total cardiovascular risk in patients with chronic obstructive pulmonary disease (COPD).
Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD
Year: 2019

Use of metoprolol succinate in patients with cardiovascular diseases associated with asthma or chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2006; 28: Suppl. 50, 502s
Year: 2006

Predictive factors for the incidence of lung cancer (LC) complicated in patients with chronic obstructive pulmonary disease (COPD)
Source: International Congress 2019 – Advances in clinical management of COPD
Year: 2019

Chronic obstructive pulmonary disease (COPD) and myocardial ischemia (MI) comorbidity
Source: Virtual Congress 2020 – Prognosis and integrated management of COPD
Year: 2020


Increased oxidative stress in patients with chronic obstructive pulmonary disease (COPD) and metabolic syndrome (MetS)
Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench
Year: 2013


Prevalence of comorbidities in patients with chronic obstructive pulmonary disease in presence of heart failure
Source: International Congress 2016 – Comorbidities and exacerbations in COPD
Year: 2016


Influence of bronchodilators on pulmonary hypertension (PH) in patients with moderate and severe chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2005; 26: Suppl. 49, 310s
Year: 2005

The state of patients with chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2007; 30: Suppl. 51, 547s
Year: 2007